Short interest in Tempus AI Inc (NASDAQ:TEM) increased during the last reporting period, rising from 17.21M to 19.96M. This put 19.74% of the company's publicly available shares short. Short ...

Phil Mickelson’s attempt to turn back the clock one more time at the Masters got off to a rocky start. The 54-year-old three-time Masters champion opened with a 3-over 75 on Thursday, leaving ...

Burlington, Ontario--(Newsfile Corp. - April 10, 2025) - Tempus Capital Inc. (CSE: TEMP) ("Tempus" or the "Company"). In a bold move to address Toronto's ongoing rental housing crisis, Tempus ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against other Tuesday’s worst-performing stocks. Wall Street’s main indices suffered a bloodbath on ...

Tempus AI share price have crashed by over 60% from the YTD high. There are concerns about the company’s growth trajectory. Technicals point to more downside, and then bounce back once the panic ...

To recap, Pelosi continued with her Congress trades in Q1 2025, adding five more equities to her portfolio, yet only one name stands out in profit: Tempus AI (NASDAQ: TEM). According to filings, TEM ...

And Charlton Hall estate is also home to the stunning Tempus hotel, which offers its guests opulent overnight stays in its lavish rooms, as well as having its own decadent bar and Orangery restaurant.

Norges Bank acquired a new position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other stocks that will profit from AI. Artificial Intelligence (AI) is no longer a concept of the ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Companies like Tempus AI TEM are leading the charge by leveraging AI for precision medicine. The stock’s 42.9% surge year to date strongly underscores a broader market shift—highlighting the ...